SILEO® is the first-and-only Health Canada-approved product for the alleviation of acute anxiety and fear associated with noise in dogs
TORONTO, Oct. 29, 2024 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced the Canadian commercial launch of SILEO® (dexmedetomidine hydrochloride oromucosal gel) to veterinary clinics throughout Canada. SILEO builds on Grey Wolf's portfolio dedicated to behaviour and anxiety health in companion animals. Dogs that experience fear and anxiety in response to loud noise such as fireworks now have a new treatment option. SILEO is available from veterinarians by prescription and can be administered at home by pet owners to help calm dogs without sedation.
Read more at newswire.ca